other material
confidence high
sentiment negative
materiality 0.50
Ekso Bionics files prospectus to sell up to $5.0M shares in at-the-market offering
EKSO BIONICS HOLDINGS, INC.
- Filed prospectus supplement under existing ATM agreement with H.C. Wainwright & Co. for up to $5.0M of common stock.
- Shares issued under effective S-3 registration statement (No. 333-272607) declared effective June 20, 2023.
- Proceeds not specified; general corporate purposes likely.